Prevalence of Toxocara and Toxascaris infection among human and animals in Iran with meta-analysis approach

BMC Infectious Diseases

Table 2 Baseline characteristics of included studies for human toxocariasis in Iran

Author(s)	Country	Publication year	Sample size	Dm^a			P^e [N (%)]	SM^f
Author(s)	Country	Publication year	Sample size	P^b	S^c	M^d	P^e [N (%)]	ELISA^g	WB^h	IFATⁱ
S. M. Sadjjadi	Shiraz	2000	519		*		133 (25.60)	*
H. Yousefi	Chaharmahal-Va Bakhtiari	2001	64		*		13 (20.31)			*
L. Akhlaghi	Kermanshah	2006	260		*		22 (8.46)	*
M. Fallah	Hamadan	2007	544		*		29 (5.30)	*
A. Nourian	Zanjan	2007	810		*		22 (2.70)	*
S. M. Alavi	Khuzestan	2008	115		*		16 (13.9)	*
M. Sharif	Mazandaran	2010	1210		*		302 (25.00)	*
S. M. Alavi	Khuzestan	2011	203		*		4 (2.00)	*
Kh. Agin	Tehran	2012	89		*		14 (16.00)	*
M. Zibaei	Lorestan	2013	85		*		3 (3.50)	*	*
Y. Gharedaghi	East Azerbaijan	2014	336		*		99 (29.46)	*
Sh. Khademvatan	Khuzestan	2014	95		*		4 (4.30)	*	*
M. Zibaei	Shiraz	2015	98		*		33 (33.67)	*	*
A. Hosseini Safa	Isfahan	2015	427		*		6 (1.39)	*
S. Allahdin	Khuzestan	2015	144		*		2 (1.38)	*	*
F. Berenji	Khorasan	2016	93		*		1 (1.07)	*
T. Momeni	West Azerbaijan	2016	397		*		12 (3.00)	*
M. Kh. Shahraki	Sistan and Baluchestan	2017	364		*		14 (3.8)	*
H. Mahmoudvand	Lorestan	2018	316		*		14 (4.40)	*
S. Shokouhi	Ilam	2018	383		*		84 (22.00)	*
M. Beiromvand	Khuzestan	2018	400		*		11 (2.70)	*
Z. Baghani	Tehran	2018	374		*		21 (5.60)	*
S. Khoshnood	Ilam	2018	300		*		35 (11.70)	*
S. Ashtari	Urmia	2018	1002		*		172 (17.22)	*
B. Sarkari	Shiraz	2018	617		*		39 (6.30)	*
S. Aghamolaie	Mazandaran	2018	630		*		148 (23.50)	*
V. Raissi	Ilam	2018	539		*		97 (17.99)	*
M. K. Shahraki	Sistan and Baluchestan	2019	963		*		17 (1.70)	*

^aDetection method, ^bParasitology, ^cSerology, ^dMolecular, ^ePrevalence, ^fSerological method, ^gEnzyme-linked immunosorbent assay, ^hWestern blot, ⁱIndirect fluorescent antibody test

ISSN: 1471-2334